13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
![](/mel/img/quote_button.gif) |
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
87,540 |
19.06.24 14:12:54 |
-0,990 |
-1,12% |
87,460 |
87,520 |
87,890 |
88,530 |
![](/mel/img/quote_button.gif) |
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
964,400 |
19.06.24 08:18:23 |
-5,200 |
-0,54% |
963,800 |
969,800 |
964,400 |
969,600 |